Business Wire | Oct 19, 2020 10:00AM EDT

2nd Annual Gabelli Funds - Columbia Business School Healthcare Symposium (Virtual)

Oct. 19, 2020

GREENWICH, Conn.--(BUSINESS WIRE)--Oct. 19, 2020--Join us as we discuss today's pressing healthcare issues.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20201019005535/en/

Bunny Ellerin, Director, HPM, Columbia Business School, MBA, Harvard Business School, BA, Columbia University (Photo: Business Wire)

CO-HOSTS:

Bunny Ellerin Jing He Director, HPM, Columbia Business Biotech Analyst, Gabelli Funds School * MBA, Harvard Business School * MBA, Columbia Business School

* BA, Columbia University * MA, Washington University in St. Louis

* BS, Peking University

Time Agenda Welcome9:00 - * Bunny Ellerin, Director, Healthcare and Pharmaceutical Management9:10 AM Program

Vaccines & Therapeutics to Treat COVID-19 * David Hering, Regional President, North America, Pfizer Vaccines

* Dr. Jacqueline Miller, Senior Vice President, Infectious9:10 - Diseases, Moderna10:00 AM * Dr. David Weinreich, Senior Vice President, Global Clinical Development, Regeneron

* (Moderator) Jing He '15, Biotech Analyst, Gabelli Funds

Health Policy & Reimbursement Trends * Dr. Deepa Kumaraiah, Senior Vice President, Service Lines and Chief Physician, NYP Medical Groups, New York-Presbyterian

* Melissa Schulman, Senior Vice President of Government Affairs,10:10 - CVS Health11:00 AM * Professor Michael Sparer, Chair, Health Policy and Management, Columbia University Mailman School of Public Health

* (Moderator) Jeff Jonas, Portfolio Manager, Gabelli Funds

Healthcare Delivery in a Virtual World * Dr. Amy Fahrenkopf, President, HSS Health and Senior Vice President, Hospital for Special Surgery

11:10 - * Jason Gorevic, CEO, Teladoc HealthNoon * Dr. Julie Silverstein, Divisional President, Oak Street Health

* (Moderator) Kevin Kedra, Healthcare Analyst, G.research

Click Here to Register

Gabelli Funds, LLC is a registered investment adviser with the Securities and Exchange Commission and is a wholly owned subsidiary of GAMCO Investors, Inc. (NYSE: GBL).

View source version on businesswire.com: https://www.businesswire.com/news/home/20201019005535/en/

CONTACT: Douglas R. Jamieson 914-921-5020 djamieson@gabelli.com